Jie Lu

Kigamicin D, a novel anticancer agent based on a new anti‐austerity strategy targeting cancer cells' tolerance to nutrient starvation

Jie Lu, Setsuko Kunimoto, Yohko Yamazaki et al. · Cancer Science · 2004 · 104 citations · Full text

Amlexanox, a selective inhibitor of IKBKE, generates anti-tumoral effects by disrupting the Hippo pathway in human glioblastoma cell lines

Yang Liu, Jie Lu, Zhimeng Zhang et al. · Cell Death and Disease · 2017 · 72 citations · Full text

Neuro-oncology, Hippo Pathway, Glioblastoma Multiforme +12

α-Glucosidase from a strain of deep-sea Geobacillus: a potential enzyme for the biosynthesis of complex carbohydrates

Vo Si Hung, Yuji Hatada, Saori Goda et al. · Applied Microbiology and Biotechnology · 2005 · 55 citations

Biosynthesis, Biochemistry, Natural Sciences +12

IKBKE regulates cell proliferation and epithelial-mesenchymal transition of human malignant glioma via the Hippo pathway

Jie Lu, Yi Yang, Gaochao Guo et al. · Oncotarget · 2017 · 34 citations · Full text

Polydatin Induces Apoptosis and Inhibits Growth of Acute Monocytic Leukemia Cells

Chunmei Wang, Yuan Luo, Jie Lu et al. · Journal of Biochemical and Molecular Toxicology · 2015 · 27 citations

Mixed-phenotype Acute Leukemia, Apoptosis, Immunology +18